Should we use Palivizumab immunoprophylaxis for infants against respiratory syncytial virus? – a cost-utility analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-4015
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Should we use Palivizumab immunoprophylaxis for infants against respiratory syncytial virus? – a cost-utility analysis ; volume:7 ; number:1 ; day:17 ; month:12 ; year:2018 ; pages:1-14 ; date:12.2018
Israel Journal of Health Policy Research ; 7, Heft 1 (17.12.2018), 1-14, 12.2018
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Ginsberg, Gary M.
Somekh, Eli
Schlesinger, Yechiel
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13584-018-0258-4
- URN
-
urn:nbn:de:101:1-2019030513275505164385
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ginsberg, Gary M.
- Somekh, Eli
- Schlesinger, Yechiel
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cost-utility analysis of palivizumab for preventing respiratory syncytial virus in preterm neonates and infants in Colombia
Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain
Cost-utility analysis of palivizumab in Italy: results from a simulation model in the prophylaxis of respiratory syncytial virus infection (RSV) among high-risk preterm infants
Should Colorectal Cancer Screening in Portugal Start at the Age of 45 Years? A Cost-Utility Analysis
Cost-utility of tiotropium in patients with severe asthma
Cost-utility analysis of an implant treatment in dentistry
Cost–utility analysis of a palliative care program in Colombia
Economic efficiency and QALY-based cost-utility analysis in health care
Cost-utility analysis of the UPRIGHT intervention promoting resilience in adolescents
A cost-utility analysis of multimodal pain rehabilitation in primary healthcare
Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia
Podotimod in pediatric recurrent respiratory tract infections: a cost-utility analysis
Cost-utility analysis of palivizumab for preventing respiratory syncytial virus in preterm neonates and infants in Colombia
Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain
Cost-utility analysis of palivizumab in Italy: results from a simulation model in the prophylaxis of respiratory syncytial virus infection (RSV) among high-risk preterm infants
Should Colorectal Cancer Screening in Portugal Start at the Age of 45 Years? A Cost-Utility Analysis
Cost-utility of tiotropium in patients with severe asthma
Cost-utility analysis of an implant treatment in dentistry
Cost–utility analysis of a palliative care program in Colombia
Economic efficiency and QALY-based cost-utility analysis in health care
Cost-utility analysis of the UPRIGHT intervention promoting resilience in adolescents
A cost-utility analysis of multimodal pain rehabilitation in primary healthcare
Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia
Podotimod in pediatric recurrent respiratory tract infections: a cost-utility analysis
Cost-utility analysis of palivizumab for preventing respiratory syncytial virus in preterm neonates and infants in Colombia
Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain
Cost-utility analysis of palivizumab in Italy: results from a simulation model in the prophylaxis of respiratory syncytial virus infection (RSV) among high-risk preterm infants
Should Colorectal Cancer Screening in Portugal Start at the Age of 45 Years? A Cost-Utility Analysis
Cost-utility of tiotropium in patients with severe asthma
Cost-utility analysis of an implant treatment in dentistry
Cost–utility analysis of a palliative care program in Colombia
Economic efficiency and QALY-based cost-utility analysis in health care
Cost-utility analysis of the UPRIGHT intervention promoting resilience in adolescents
A cost-utility analysis of multimodal pain rehabilitation in primary healthcare
Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia